The global Opioid Use Disorder market is projected to grow from US$ 1907.4 million in 2024 to US$ 2660 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.7% during the forecast period.

Opioid Use Disorder Market

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

Market Analysis and Insights: Global Opioid Use Disorder Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Opioid Use Disorder market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Opioid Use Disorder, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Opioid Use Disorder, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Opioid Use Disorder revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Opioid Use Disorder market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Opioid Use Disorder revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Opioid Use Disorder Market Report

Report Metric	Details
Report Name	Opioid Use Disorder Market
Accounted market size in 2024	US$ 1907.4 million
Forecasted market size in 2030	US$ 2660 million
CAGR	5.7
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Buprenorphine Methadone Naltrexone
Segment by Application	Moderate Pain Treatment Severe Pain Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Opioid Use Disorder in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Use Disorder companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Use Disorder revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Opioid Use Disorder Market growing?

Ans: The Opioid Use Disorder Market witnessing a CAGR of 5.7 during the forecast period 2025-2030.

What is the Opioid Use Disorder Market size in 2030?

Ans: The Opioid Use Disorder Market size in 2030 will be US$ 2660 million.

Who are the main players in the Opioid Use Disorder Market report?

Ans: The main players in the Opioid Use Disorder Market are Indivior, Alkermes, Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros

What are the Application segmentation covered in the Opioid Use Disorder Market report?

Ans: The Applications covered in the Opioid Use Disorder Market report are Moderate Pain Treatment, Severe Pain Treatment

What are the Type segmentation covered in the Opioid Use Disorder Market report?

Ans: The Types covered in the Opioid Use Disorder Market report are Buprenorphine, Methadone, Naltrexone

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Opioid Use Disorder Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Buprenorphine

1.2.3 Methadone

1.2.4 Naltrexone

1.3 Market by Application

1.3.1 Global Opioid Use Disorder Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Moderate Pain Treatment

1.3.3 Severe Pain Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Opioid Use Disorder Market Perspective (2019-2030)

2.2 Global Opioid Use Disorder Growth Trends by Region

2.2.1 Opioid Use Disorder Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Opioid Use Disorder Historic Market Size by Region (2019-2024)

2.2.3 Opioid Use Disorder Forecasted Market Size by Region (2025-2030)

2.3 Opioid Use Disorder Market Dynamics

2.3.1 Opioid Use Disorder Industry Trends

2.3.2 Opioid Use Disorder Market Drivers

2.3.3 Opioid Use Disorder Market Challenges

2.3.4 Opioid Use Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Opioid Use Disorder by Players

3.1.1 Global Opioid Use Disorder Revenue by Players (2019-2024)

3.1.2 Global Opioid Use Disorder Revenue Market Share by Players (2019-2024)

3.2 Global Opioid Use Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Opioid Use Disorder, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Opioid Use Disorder Market Concentration Ratio

3.4.1 Global Opioid Use Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Opioid Use Disorder Revenue in 2023

3.5 Global Key Players of Opioid Use Disorder Head office and Area Served

3.6 Global Key Players of Opioid Use Disorder, Product and Application

3.7 Global Key Players of Opioid Use Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid Use Disorder Breakdown Data by Type

4.1 Global Opioid Use Disorder Historic Market Size by Type (2019-2024)

4.2 Global Opioid Use Disorder Forecasted Market Size by Type (2025-2030)

5 Opioid Use Disorder Breakdown Data by Application

5.1 Global Opioid Use Disorder Historic Market Size by Application (2019-2024)

5.2 Global Opioid Use Disorder Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Opioid Use Disorder Market Size (2019-2030)

6.2 North America Opioid Use Disorder Market Size by Type

6.2.1 North America Opioid Use Disorder Market Size by Type (2019-2024)

6.2.2 North America Opioid Use Disorder Market Size by Type (2025-2030)

6.2.3 North America Opioid Use Disorder Market Share by Type (2019-2030)

6.3 North America Opioid Use Disorder Market Size by Application

6.3.1 North America Opioid Use Disorder Market Size by Application (2019-2024)

6.3.2 North America Opioid Use Disorder Market Size by Application (2025-2030)

6.3.3 North America Opioid Use Disorder Market Share by Application (2019-2030)

6.4 North America Opioid Use Disorder Market Size by Country

6.4.1 North America Opioid Use Disorder Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Opioid Use Disorder Market Size by Country (2019-2024)

6.4.3 North America Opioid Use Disorder Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Opioid Use Disorder Market Size (2019-2030)

7.2 Europe Opioid Use Disorder Market Size by Type

7.2.1 Europe Opioid Use Disorder Market Size by Type (2019-2024)

7.2.2 Europe Opioid Use Disorder Market Size by Type (2025-2030)

7.2.3 Europe Opioid Use Disorder Market Share by Type (2019-2030)

7.3 Europe Opioid Use Disorder Market Size by Application

7.3.1 Europe Opioid Use Disorder Market Size by Application (2019-2024)

7.3.2 Europe Opioid Use Disorder Market Size by Application (2025-2030)

7.3.3 Europe Opioid Use Disorder Market Share by Application (2019-2030)

7.4 Europe Opioid Use Disorder Market Size by Country

7.4.1 Europe Opioid Use Disorder Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Opioid Use Disorder Market Size by Country (2019-2024)

7.4.3 Europe Opioid Use Disorder Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Opioid Use Disorder Market Size (2019-2030)

8.2 China Opioid Use Disorder Market Size by Type

8.2.1 China Opioid Use Disorder Market Size by Type (2019-2024)

8.2.2 China Opioid Use Disorder Market Size by Type (2025-2030)

8.2.3 China Opioid Use Disorder Market Share by Type (2019-2030)

8.3 China Opioid Use Disorder Market Size by Application

8.3.1 China Opioid Use Disorder Market Size by Application (2019-2024)

8.3.2 China Opioid Use Disorder Market Size by Application (2025-2030)

8.3.3 China Opioid Use Disorder Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Opioid Use Disorder Market Size (2019-2030)

9.2 Asia Opioid Use Disorder Market Size by Type

9.2.1 Asia Opioid Use Disorder Market Size by Type (2019-2024)

9.2.2 Asia Opioid Use Disorder Market Size by Type (2025-2030)

9.2.3 Asia Opioid Use Disorder Market Share by Type (2019-2030)

9.3 Asia Opioid Use Disorder Market Size by Application

9.3.1 Asia Opioid Use Disorder Market Size by Application (2019-2024)

9.3.2 Asia Opioid Use Disorder Market Size by Application (2025-2030)

9.3.3 Asia Opioid Use Disorder Market Share by Application (2019-2030)

9.4 Asia Opioid Use Disorder Market Size by Region

9.4.1 Asia Opioid Use Disorder Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Opioid Use Disorder Market Size by Region (2019-2024)

9.4.3 Asia Opioid Use Disorder Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Opioid Use Disorder Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Type

10.2.1 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Opioid Use Disorder Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Application

10.3.1 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Opioid Use Disorder Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country

10.4.1 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Indivior

11.1.1 Indivior Company Details

11.1.2 Indivior Business Overview

11.1.3 Indivior Opioid Use Disorder Introduction

11.1.4 Indivior Revenue in Opioid Use Disorder Business (2019-2024)

11.1.5 Indivior Recent Developments

11.2 Alkermes

11.2.1 Alkermes Company Details

11.2.2 Alkermes Business Overview

11.2.3 Alkermes Opioid Use Disorder Introduction

11.2.4 Alkermes Revenue in Opioid Use Disorder Business (2019-2024)

11.2.5 Alkermes Recent Developments

11.3 Titan Pharmaceuticals

11.3.1 Titan Pharmaceuticals Company Details

11.3.2 Titan Pharmaceuticals Business Overview

11.3.3 Titan Pharmaceuticals Opioid Use Disorder Introduction

11.3.4 Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.3.5 Titan Pharmaceuticals Recent Developments

11.4 Hikma Pharmaceuticals

11.4.1 Hikma Pharmaceuticals Company Details

11.4.2 Hikma Pharmaceuticals Business Overview

11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Introduction

11.4.4 Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.4.5 Hikma Pharmaceuticals Recent Developments

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Details

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Opioid Use Disorder Introduction

11.5.4 Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024)

11.5.5 Teva Pharmaceuticals Recent Developments

11.6 MediciNova

11.6.1 MediciNova Company Details

11.6.2 MediciNova Business Overview

11.6.3 MediciNova Opioid Use Disorder Introduction

11.6.4 MediciNova Revenue in Opioid Use Disorder Business (2019-2024)

11.6.5 MediciNova Recent Developments

11.7 Orexo

11.7.1 Orexo Company Details

11.7.2 Orexo Business Overview

11.7.3 Orexo Opioid Use Disorder Introduction

11.7.4 Orexo Revenue in Opioid Use Disorder Business (2019-2024)

11.7.5 Orexo Recent Developments

11.8 Camurus

11.8.1 Camurus Company Details

11.8.2 Camurus Business Overview

11.8.3 Camurus Opioid Use Disorder Introduction

11.8.4 Camurus Revenue in Opioid Use Disorder Business (2019-2024)

11.8.5 Camurus Recent Developments

11.9 Omeros

11.9.1 Omeros Company Details

11.9.2 Omeros Business Overview

11.9.3 Omeros Opioid Use Disorder Introduction

11.9.4 Omeros Revenue in Opioid Use Disorder Business (2019-2024)

11.9.5 Omeros Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alkermes plc

Titan pharmaceuticals

Hikma Pharmaceuticals

List of Tables

Table 1. Global Opioid Use Disorder Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Buprenorphine

Table 3. Key Players of Methadone

Table 4. Key Players of Naltrexone

Table 5. Global Opioid Use Disorder Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 6. Global Opioid Use Disorder Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Opioid Use Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Opioid Use Disorder Market Share by Region (2019-2024)

Table 9. Global Opioid Use Disorder Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Opioid Use Disorder Market Share by Region (2025-2030)

Table 11. Opioid Use Disorder Market Trends

Table 12. Opioid Use Disorder Market Drivers

Table 13. Opioid Use Disorder Market Challenges

Table 14. Opioid Use Disorder Market Restraints

Table 15. Global Opioid Use Disorder Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Opioid Use Disorder Revenue Share by Players (2019-2024)

Table 17. Global Top Opioid Use Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2023)

Table 18. Global Opioid Use Disorder Industry Ranking 2022 VS 2023 VS 2024

Table 19. Global 5 Largest Players Market Share by Opioid Use Disorder Revenue (CR5 and HHI) & (2019-2024)

Table 20. Global Key Players of Opioid Use Disorder, Headquarters and Area Served

Table 21. Global Key Players of Opioid Use Disorder, Product and Application

Table 22. Global Key Players of Opioid Use Disorder, Product and Application

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Opioid Use Disorder Revenue Market Share by Type (2019-2024)

Table 26. Global Opioid Use Disorder Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Opioid Use Disorder Revenue Market Share by Type (2025-2030)

Table 28. Global Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Opioid Use Disorder Revenue Share by Application (2019-2024)

Table 30. Global Opioid Use Disorder Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Opioid Use Disorder Revenue Share by Application (2025-2030)

Table 32. North America Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 33. North America Opioid Use Disorder Market Size by Type (2025-2030) & (US$ Million)

Table 34. North America Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 35. North America Opioid Use Disorder Market Size by Application (2025-2030) & (US$ Million)

Table 36. North America Opioid Use Disorder Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. North America Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 38. North America Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 39. Europe Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 40. Europe Opioid Use Disorder Market Size by Type (2025-2030) & (US$ Million)

Table 41. Europe Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 42. Europe Opioid Use Disorder Market Size by Application (2025-2030) & (US$ Million)

Table 43. Europe Opioid Use Disorder Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Europe Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 45. Europe Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 46. China Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 47. China Opioid Use Disorder Market Size by Type (2025-2030) & (US$ Million)

Table 48. China Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 49. China Opioid Use Disorder Market Size by Application (2025-2030) & (US$ Million)

Table 50. Asia Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 51. Asia Opioid Use Disorder Market Size by Type (2025-2030) & (US$ Million)

Table 52. Asia Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 53. Asia Opioid Use Disorder Market Size by Application (2025-2030) & (US$ Million)

Table 54. Asia Opioid Use Disorder Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 55. Asia Opioid Use Disorder Market Size by Region (2019-2024) & (US$ Million)

Table 56. Asia Opioid Use Disorder Market Size by Region (2025-2030) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Type (2019-2024) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Type (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Application (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Application (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Opioid Use Disorder Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 62. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country (2019-2024) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Opioid Use Disorder Market Size by Country (2025-2030) & (US$ Million)

Table 64. Indivior Company Details

Table 65. Indivior Business Overview

Table 66. Indivior Opioid Use Disorder Product

Table 67. Indivior Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 68. Indivior Recent Developments

Table 69. Alkermes Company Details

Table 70. Alkermes Business Overview

Table 71. Alkermes Opioid Use Disorder Product

Table 72. Alkermes Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 73. Alkermes Recent Developments

Table 74. Titan Pharmaceuticals Company Details

Table 75. Titan Pharmaceuticals Business Overview

Table 76. Titan Pharmaceuticals Opioid Use Disorder Product

Table 77. Titan Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 78. Titan Pharmaceuticals Recent Developments

Table 79. Hikma Pharmaceuticals Company Details

Table 80. Hikma Pharmaceuticals Business Overview

Table 81. Hikma Pharmaceuticals Opioid Use Disorder Product

Table 82. Hikma Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 83. Hikma Pharmaceuticals Recent Developments

Table 84. Teva Pharmaceuticals Company Details

Table 85. Teva Pharmaceuticals Business Overview

Table 86. Teva Pharmaceuticals Opioid Use Disorder Product

Table 87. Teva Pharmaceuticals Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 88. Teva Pharmaceuticals Recent Developments

Table 89. MediciNova Company Details

Table 90. MediciNova Business Overview

Table 91. MediciNova Opioid Use Disorder Product

Table 92. MediciNova Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 93. MediciNova Recent Developments

Table 94. Orexo Company Details

Table 95. Orexo Business Overview

Table 96. Orexo Opioid Use Disorder Product

Table 97. Orexo Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 98. Orexo Recent Developments

Table 99. Camurus Company Details

Table 100. Camurus Business Overview

Table 101. Camurus Opioid Use Disorder Product

Table 102. Camurus Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 103. Camurus Recent Developments

Table 104. Omeros Company Details

Table 105. Omeros Business Overview

Table 106. Omeros Opioid Use Disorder Product

Table 107. Omeros Revenue in Opioid Use Disorder Business (2019-2024) & (US$ Million)

Table 108. Omeros Recent Developments

Table 109. Research Programs/Design for This Report

Table 110. Key Data Information from Secondary Sources

Table 111. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Opioid Use Disorder Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Opioid Use Disorder Market Share by Type: 2023 VS 2030

Figure 3. Buprenorphine Features

Figure 4. Methadone Features

Figure 5. Naltrexone Features

Figure 6. Global Opioid Use Disorder Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Opioid Use Disorder Market Share by Application: 2023 VS 2030

Figure 8. Moderate Pain Treatment Case Studies

Figure 9. Severe Pain Treatment Case Studies

Figure 10. Opioid Use Disorder Report Years Considered

Figure 11. Global Opioid Use Disorder Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Opioid Use Disorder Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Opioid Use Disorder Market Share by Region: 2023 VS 2030

Figure 14. Global Opioid Use Disorder Market Share by Players in 2023

Figure 15. Global Top Opioid Use Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Use Disorder as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Opioid Use Disorder Revenue in 2023

Figure 17. North America Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Opioid Use Disorder Market Share by Type (2019-2030)

Figure 19. North America Opioid Use Disorder Market Share by Application (2019-2030)

Figure 20. North America Opioid Use Disorder Market Share by Country (2019-2030)

Figure 21. United States Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Opioid Use Disorder Market Size YoY (2019-2030) & (US$ Million)

Figure 24. Europe Opioid Use Disorder Market Share by Type (2019-2030)

Figure 25. Europe Opioid Use Disorder Market Share by Application (2019-2030)

Figure 26. Europe Opioid Use Disorder Market Share by Country (2019-2030)

Figure 27. Germany Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. China Opioid Use Disorder Market Size YoY (2019-2030) & (US$ Million)

Figure 34. China Opioid Use Disorder Market Share by Type (2019-2030)

Figure 35. China Opioid Use Disorder Market Share by Application (2019-2030)

Figure 36. Asia Opioid Use Disorder Market Size YoY (2019-2030) & (US$ Million)

Figure 37. Asia Opioid Use Disorder Market Share by Type (2019-2030)

Figure 38. Asia Opioid Use Disorder Market Share by Application (2019-2030)

Figure 39. Asia Opioid Use Disorder Market Share by Region (2019-2030)

Figure 40. Japan Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. South Korea Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. China Taiwan Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. India Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Australia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Opioid Use Disorder Market Size YoY (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Opioid Use Disorder Market Share by Type (2019-2030)

Figure 48. Middle East, Africa, and Latin America Opioid Use Disorder Market Share by Application (2019-2030)

Figure 49. Middle East, Africa, and Latin America Opioid Use Disorder Market Share by Country (2019-2030)

Figure 50. Brazil Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Mexico Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Turkey Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Israel Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. GCC Countries Opioid Use Disorder Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Indivior Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 57. Alkermes Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 58. Titan Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 60. Teva Pharmaceuticals Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 61. MediciNova Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 62. Orexo Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 63. Camurus Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 64. Omeros Revenue Growth Rate in Opioid Use Disorder Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions